P85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response

Oncogene

Volumn 30, Issue 11, 2011, Pages 1360-1371

  Song, L ^a,b   Gao, M ^b   Dong, W ^b   Hu, M ^b   Li, J ^a   Shi, X ^a   Hao, Y ^b   Li, Y ^b   Huang, C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

acetylation; p300; p53; p85 ; UVB radiation

Indexed keywords

LYSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P300; PROTEIN P53; PROTEIN P85;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENE TARGETING; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTON TRANSPORT; RADIATION EXPOSURE; ULTRAVIOLET B RADIATION;

ACETYLATION; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; E1A-ASSOCIATED P300 PROTEIN; GENES, P53; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTIONAL ACTIVATION; ULTRAVIOLET RAYS;

EID: 79952769252     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.506     Document Type: Article

References (52)

1. An W, Kim J, Roeder RG. (2004). Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117: 735-748. (Pubitemid 38748890)
2. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184. (Pubitemid 127678750)
3. Brooks CL, Gu W. (2003). Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171. (Pubitemid 36332191)
4. Brooks CL, Gu W. (2008). p53 activation: a case against Sir. Cancer Cell 13: 377-378. (Pubitemid 351609448)
5. Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A et al. (2008). SIRT1 confers protection against UVB- and H(2)O(2)-induced cell death via modulation of p53 and JNK in cultured skin keratino-cytes. J Cell Mol Med 4: 4.
6. Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T et al. (2006). Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 26: 6859-6869. (Pubitemid 44387635)
7. Eischen CM, Lozano G. (2009). p53 and MDM2: antagonists or partners in crime? Cancer Cell 15: 161-162.
8. Feng L, Lin T, Uranishi H, Gu W, Xu Y. (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 25: 5389-5395. (Pubitemid 40853576)
9. Geering B, Cutillas PR, Vanhaesebroeck B. (2007). Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? Biochem Soc Trans 35: 199-203. (Pubitemid 46596467)
10. Goodman RH, Smolik S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14: 1553-1577. (Pubitemid 30460905)
11. Grossman SR. (2001). p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268: 2773-2778. (Pubitemid 32862958)
12. Gu W, Roeder RG. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606. (Pubitemid 27357952)
13. Haupt Y, Maya R, Kazaz A, Oren M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299. (Pubitemid 27220766)
14. Iyer NG, Ozdag H, Caldas C. (2004). p300/CBP and cancer. Oncogene 23: 4225-4231. (Pubitemid 38758588)
15. Juan L-J, Shia W-J, Chen M-H, Yang W-M, Seto E, Lin Y-S et al. (2000). Histone deacetylases specifically down-regulate p53-depen-dent gene activation. J Biol Chem 275: 20436-20443. (Pubitemid 30457621)
16. Kim EJ, Kho JH, Kang MR, Um SJ. (2007). Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28: 277-290.
17. Kitagawa M, Lee SH, McCormick F. (2008). Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 29: 217-231. (Pubitemid 351172826)
18. Kruse JP, Gu W. (2009). Modes of p53 regulation. Cell 137: 609-622.
19. Kubbutat MHG, Jones SN, Vousden KH. (1997). Regulation of p53 stability by Mdm2. Nature 387: 299-303. (Pubitemid 27220767)
20. Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H et al. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 29: 392-400. (Pubitemid 351215939)
21. Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M et al. (2008). Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13: 454-463. (Pubitemid 351609441)
22. Latonen L, Laiho M. (2005). Cellular UV damage responses- functions of tumor suppressor p53. Biochim Biophys Acta 1755: 71-89. (Pubitemid 40982559)
23. Levine AJ, Hu W, Feng Z. (2006). The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036.
24. Li M, Luo J, Brooks CL, Gu W. (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611. (Pubitemid 36042220)
25. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827. (Pubitemid 27270910)
26. Liu G, Chen X. (2006). Regulation of the p53 transcriptional activity. J Cell Biochem 97: 448-458. (Pubitemid 43265305)
27. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. (1999). p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209. (Pubitemid 29046862)
28. Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC. (2005). The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170: 455-464. (Pubitemid 41126944)
29. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. (2004). Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Prog Natl Acad Sci USA 101: 2259-2264. (Pubitemid 38269299)
30. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148. (Pubitemid 33035941)
31. Luo J, Su F, Chen D, Shiloh A, Gu W. (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381.
32. Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274. (Pubitemid 46962095)
33. Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y et al. (2007). Mechanism of two classes of cancer mutations in the phosphoinosi-tide 3-kinase catalytic subunit. Science 317: 239-242. (Pubitemid 47076198)
34. Olsson A, Manzl C, Strasser A, Villunger A. (2007). How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14: 1561-1575. (Pubitemid 47278842)
35. Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T et al. (2009). Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 106: 3788-3793.
36. Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H et al. (2005). ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol 25: 6639-6648. (Pubitemid 41023237)
37. Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T. (2003). Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol Cancer Res 1: 1048-1057. (Pubitemid 38044980)
38. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841. (Pubitemid 28440142)
39. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21: 848-861. (Pubitemid 46572363)
40. Song L, Li J, Hu M, Huang C. (2008). Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. Exp Cell Res 314: 2187-2198.
41. Song L, Li J, Ye J, Yu G, Ding J, Zhang D et al. (2007). p85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol Cell Biol 27: 2713-2731. (Pubitemid 46581360)
42. Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q et al. (2006). IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J Cell Biol 175: 607-617. (Pubitemid 44790614)
43. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851. (Pubitemid 44960096)
44. Tang Y, Luo J, Zhang W, Gu W. (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24: 827-839. (Pubitemid 44960094)
45. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. (2008). Acetylation is indispensable for p53 activation. Cell 133: 612-626. (Pubitemid 351636297)
46. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR. (2002a). Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22: 965-977. (Pubitemid 34053073)
47. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR et al. (2002b). Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 99: 419-424. (Pubitemid 34060376)
48. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159. (Pubitemid 33035942)
49. Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z et al. (2005). Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor {kappa}B induced by UV radiation. Cancer Res 65: 6601-6611. (Pubitemid 41060696)
50. Yin Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y et al. (1998). Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391: 707-710. (Pubitemid 28113219)
51. Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W. (2008). Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451: 587-590. (Pubitemid 351186268)
52. Zhu Z, Luo Z, Li Y, Ni C, Li H, Zhu M. (2009). Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 49: 504-512.